EMA Authorised: Yaxwer (denosumab) — Gedeon Richter Plc.

View source ↗

Summary

EMA authorised Yaxwer (denosumab) by Gedeon Richter for the treatment of giant cell tumor of bone in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Yaxwer (denosumab)

Snippet

Status: Authorised. Therapeutic area: Neoplasms, Bone Tissue;Giant Cell Tumor of Bone. MAH: Gedeon Richter Plc.. Decision date: 23/06/2025